argenx SE (ARGX)
1028.68
-2.98
(-0.29%)
USD |
NASDAQ |
Sep 01, 16:00
1028.68
0.00 (0.00%)
After-Hours: 20:00
argenx Cash from Operations (TTM) : 1.160B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.160B |
| December 31, 2025 | 845.65M |
| June 30, 2025 | 542.69M |
| December 31, 2024 | 28.85M |
| June 30, 2024 | -145.54M |
| December 31, 2023 | -328.06M |
| June 30, 2023 | -619.12M |
| December 31, 2022 | -851.15M |
| June 30, 2022 | -869.97M |
| December 31, 2021 | -602.62M |
| June 30, 2021 | -472.14M |
| Date | Value |
|---|---|
| December 31, 2020 | -393.48M |
| June 30, 2020 | -248.60M |
| December 31, 2019 | 155.39M |
| June 30, 2019 | 230.87M |
| December 31, 2018 | -60.44M |
| June 30, 2018 | -57.62M |
| December 31, 2017 | -42.54M |
| June 30, 2017 | -30.13M |
| December 31, 2016 | 11.71M |
| June 30, 2016 | 15.80M |
| December 31, 2015 | -15.20M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Autolus Therapeutics Plc | -224.98M |
| Akari Therapeutics Plc | -10.74M |
| Forte Biosciences, Inc. | -71.98M |
| Evaxion AS | -- |
| DBV Technologies SA | -169.35M |